Literature DB >> 16222550

Hemolytic uremic syndrome associated with Entamoeba histolytica intestinal infection.

Felipe Cavagnaro1, Carla Guzmán, Paul Harris.   

Abstract

Amebiasis secondary to Entamoeba histolytica (E. histolytica) continues to be a major source of morbidity and mortality worldwide, mainly in developing countries. An association between amebic dysentery and hemolytic uremic syndrome (HUS) has been mentioned, but a cause-and-effect relationship has never been confirmed. We report the case of an 11-year-old healthy white female who developed severe bloody diarrhea after drinking contaminated unboiled water, developing classic HUS and requiring acute intermittent hemodialysis. The etiological study confirmed numerous cysts and hematophagous trophozoites of E. histolytica on stool smear, but without evidence of other pathogens. This report contributes to the concept that classic post-diarrheal HUS, usually related to colitis secondary to enterohemorragic Shiga-toxin producing Escherichia coli (E.coli) strains, may be associated with other pathogens, including E. histolytica. Additional information regarding mechanisms of virulence of E. histolytica and host immunological reaction is needed to clarify the temporal association of these two disorders (HUS and amebiasis).

Entities:  

Mesh:

Year:  2005        PMID: 16222550     DOI: 10.1007/s00467-005-2069-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Survival of Escherichia coli O157 in a soil protozoan: implications for disease.

Authors:  J Barker; T J Humphrey; M W Brown
Journal:  FEMS Microbiol Lett       Date:  1999-04-15       Impact factor: 2.742

Review 2.  Amebiasis.

Authors:  Rashidul Haque; Christopher D Huston; Molly Hughes; Eric Houpt; William A Petri
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

3.  Clinical and pathophysiological aspects of immune complex glomerulonephritis associated with Entamoeba histolytica abscess of the liver.

Authors:  M Lecuit; F Martinez; G Deray; H Beaufils; M C Gubler; J P Nozais; F Bricaire; C Jacobs
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

4.  Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Authors:  Kerstin Ludwig; Volkan Sarkim; Martin Bitzan; Mohamed A Karmali; Christoph Bobrowski; Hans Ruder; Rainer Laufs; Ingo Sobottka; Martin Petric; Helge Karch; Dirk E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

5.  Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection.

Authors:  W Wang; K Keller; K Chadee
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  The haemolytic uraemic syndrome in patients with AIDS.

Authors:  P Kelleher; A Severn; C Tomson; S Lucas; J Parkin; A Pinching; R Miller
Journal:  Genitourin Med       Date:  1996-06

7.  Henoch Schönlein purpura and amebiasis.

Authors:  G Demircin; A Oner; O Erdoğan; M Bülbül; L Memiş
Journal:  Acta Paediatr Jpn       Date:  1998-10

8.  Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Authors:  Lisa M Harrison; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Entamoeba histolytica: increase of enterotoxicity and of 53- and 75-kDa cysteine proteinases in a clone of higher virulence.

Authors:  F Navarro-García; L Chávez-Dueñas; V Tsutsumi; F Posadas del Río; R López-Revilla
Journal:  Exp Parasitol       Date:  1995-05       Impact factor: 2.011

Review 10.  Microbial contamination of drinking water and disease outcomes in developing regions.

Authors:  Nicholas John Ashbolt
Journal:  Toxicology       Date:  2004-05-20       Impact factor: 4.221

View more
  2 in total

1.  The context of ethical problems in medical volunteer work.

Authors:  Anji Wall
Journal:  HEC Forum       Date:  2011-06

2.  Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.

Authors:  F Semsa Cayci; Nilgun Cakar; Veysel Sabri Hancer; Nermin Uncu; Banu Acar; Gokce Gur
Journal:  Pediatr Nephrol       Date:  2012-08-19       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.